Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Composite CLL/SLL and Lymphoplasmacytic Lymphoma with IgM Anti-MAG Neuropathy: Clinicopathologic and Molecular Characterization of a Diagnostically Challenging Case.
Exploring the impact of stress on balance and gait speed in people with multiple sclerosis.
Neuroinflammatory Remodeling by Type 2 Immune Pathways Links Allergic Signaling to Neurodegenerative Disease.
Metabolomic Signatures of Brain Atrophy and Ibudilast Response in Progressive Multiple Sclerosis.
Automated Assessment of Manual Dexterity Using a Sensorized Nine-Hole Peg Test Board: Reproducibility and Innovative Quantitative Metrics.
Integrated Blood Inflammatory Ratios and Cerebrospinal Fluid Blood‒Brain Barrier Dysfunction Predict Relapse Risk in Neuromyelitis Optica Spectrum Disorder.
Detection of a complex chromosomal rearrangement in a novel mouse mutant by optical genome mapping.
Clinical Spectrum, neuroimaging, treatment, and outcomes of dengue-associated spinal cord involvement.
Hypertonic saline protects the axo-myelinic interface acutely after contusive SCI and improves postural stability and balance as revealed by motion sequencing (MoSeq).
Mediterranean-DASH intervention for neurodegenerative delay (MIND) diet intervention in persons with multiple sclerosis: A feasibility, randomized controlled trial.
Epidemiology of multiple sclerosis in a healthcare area of the Basque Country, Northern Spain: A population-based study (2009-2023).
Effects of high-dose vitamin D supplementation in patients with multiple sclerosis: A systematic review of efficacy and safety.
Activation of the Reverse Cholesterol Transport Pathway: A Strategy to Ameliorate Lipid Metabolic Dyshomeostasis in the Microenvironment Following Spinal Cord Injury.
Myelin-driven structural network redundancy underlies cognition in cerebral small vessel disease.
Plasma ECRG4 as a novel diagnostic marker for Alzheimer's disease associated with oligodendrocyte dysfunction.
Colony Stimulating Factor-1 Receptor-Related Disorder Treated With Ilunazebart.
Severe ADEM-Like Neuroinflammatory Disease and Cerebrovascular Fragility With Recurrent Pseudoaneurysms and Moyamoya in a Familial Germline CBL Mutation: Expanding the Clinical Phenotype.
Evolution of blood biomarkers reflective of brain tissue damage and inflammation in the perioperative course of intracerebral haemorrhage evacuation in a phase II proof-of-concept trial.
Current evidence and knowledge gaps on remote monitoring in people with multiple sclerosis - a systematic scoping review.
Switching from complement inhibitors in AQP4-IgG-positive NMOSD: clinical characteristics, an operational "cluster phase" and potential strategies to prevent therapeutic gaps.
Taking progressive biology seriously in the time of B-cells and BTK.
Propionic acid in multiple sclerosis: a phase 2b, double-blind, randomized placebo-controlled trial.
Neurophysiological and Functional Assessment in Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP): The Correlation Between Visual Evoked Potentials and Grip Strength.
Microglial PD-1/PD-L1 axis in CNS demyelinating diseases: a dual immunoregulatory perspective.
Patient experiences with systematically-administered patient-reported outcome measures in multiple sclerosis.

Pages